Shares of Morepen Labs settled 2.62 per cent higher at Rs 68.45 apiece on the BSE.
Morepen Laboratories reported a net profit of Rs 30.47 crore on a consolidated basis in the April-June of the financial year 2021-22, compared to Rs 19.37 crore in the corresponding quarter last year, marking a growth of 57 per cent year-on-year. The leading pharmaceutical company announced its first quarter results for the current fiscal year on Tuesday, July 27, after which its share price gained around three per cent during the trading session.
Morepen Laboratories opened on the BSE at Rs 67.85, swinging to an intra day high of Rs 71, and an intra day low of Rs 66.60, throughout the trading session today. Shares of Morepen Labs settled 2.62 per cent higher at Rs 68.45 apiece on the BSE.